RUCHIRA S DENSERT

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry SAN DIEGO, CA NPI 1538148697

General Payments — all program years on this page

$6,848.52

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 143
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,139.91 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,139.9116

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $863.0334
2019 $965.5232
2020 $179.564
2021 $442.176
2022 $1,691.1733
2023 $1,567.1618
2024 $1,139.9116

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077938768 Janssen Pharmaceuticals, Inc $22.62 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077939358 Janssen Pharmaceuticals, Inc $113.07 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077939572 Janssen Pharmaceuticals, Inc $4.90 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086949123 Novartis Pharmaceuticals Corporation $78.12 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086949125 Novartis Pharmaceuticals Corporation $43.10 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101384868 E.R. Squibb & Sons, L.L.C. $132.04 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103625746 ABBVIE INC. $33.19 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118884193 Otsuka America Pharmaceutical, Inc. $117.71 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118884195 Otsuka America Pharmaceutical, Inc. $28.73 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118884197 Otsuka America Pharmaceutical, Inc. $121.36 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120489690 Alkermes, Inc. $25.29 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133901091 Vanda Pharmaceuticals Inc. $35.78 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148317468 Axsome Therapeutics, Inc. $121.83 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148317470 Axsome Therapeutics, Inc. $113.49 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150163596 Tempus AI, Inc $20.88 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150808546 Neurocrine Biosciences, Inc. $127.80 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.